Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  ERK inhibitor BVD-523
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
Phase I Dose-Escalation, Safety, Pharmacokinetic and Pharmacodynamic Study of BVD-523 in Patients With Advanced Malignancies
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BVD-523-01, NCI-2013-01663, NCT01781429
Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BVD-523-02, NCI-2014-02600, NCT02296242
BVD-523 with Nab-Paclitaxel and Gemcitabine Hydrochloride in Treating Patients with Metastatic Pancreatic Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201601098, NCI-2016-00104, NCT02608229
Start Over